# Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/discontinuation-of-dasatinib-in-patients-with-chronic-myeloid-leukaemia-who-have/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jun Imagawa,Hideo Tanaka,Masaya Okada,Hirohisa Nakamae,Masayuki Hino,Kazunori Murai,Yoji Ishida,Takashi Kumagai,Seiichi Sato,Kazuteru Ohashi,Hisashi Sakamaki,Hisashi Wakita,Nobuhiko Uoshima,Yasunori Nakagawa,Yosuke Minami,Masahiro Ogasawara,Tomoharu Takeoka,Hiroshi Akasaka,Takahiko Utsumi,Naokuni Uike,Tsutomu Sato,Sachiko Ando,Kensuke Usuki,Satoshi Morita,Junichi Sakamoto,Shinya Kimura |
| Citations | 302 |
| DOI | 10.1016/s2352-3026(15)00196-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2189113171 |
| PMID | 26686407 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Kensuke Usuki](https://scholariq.org/researchers/kensuke-usuki/)

## Paper primary topic

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Paper topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.